A chamber that claims to concentrate and transfer 'radiation' from a young biodonor organism (plant sprouts) to a person — said to convey 'biological / hereditary field information' for rejuvenation, cure, or lifespan extension. The reflector geometry and plant ultraweak photon emission are real as physics objects; the field-information-transfer doctrine is unsupported and untrialled. Russian utility patents exist — an IP fact, not efficacy.
Biotron is not one device but a lineage of “bio-energy field” chambers in the information / bioresonance family. The shared claim is that a chamber can concentrate and transfer the “radiation” of a young biodonor organism — in the patents, plant sprouts — to a person, conveying “biological” or “hereditary field information” that rejuvenates, cures disease, or extends lifespan. It descends from Jiang Kanzheng's field-guidance cabin and runs through post-Soviet builders; see where these ideas come from for the wider, transnational pattern.
Two things here are real as physics objects. The first is the geometry: spherical and ellipsoidal aluminium reflectors, a waveguide, and a focal zone are ordinary optical/RF hardware that genuinely concentrate radiation. The second is that germinating plants do emit ultraweak photons — the same measurable emission credited under biophoton / UPE. Neither supports the doctrine built on them. A reflector can focus a faint photon flux; it cannot transfer “hereditary field information,” and a measurable emission is not a rejuvenation signal. This is the atlas's recurring split — keep the instrument and the measurement, set aside the interpretation.
The original “field-guidance” chamber (场导舱) is Jiang Kanzheng's; its claims — adult tooth and hair regrowth driven by plant electromagnetic fields — contradict developmental biology and carry no peer-reviewed footprint. It has its own entry and is not repeated here. The Biotron line is what later builders made of that idea.
The most developed branch is Evgeny Komrakov's Biotron-EKOM (also marketed as LifeXtron), the subject of Russian utility patent RU 2533058 (international family WO 2011028147 A2). Its distinguishing idea is purely geometric: truncated-spherical reflector “antennae” and sprout trays are arranged so their focal zones coincide at the centre of the device, concentrating the claimed emission — explicitly avoiding electronic amplifiers in the passive variants (“Большой” and “Малый Биотрон” — Large and Small Biotron). A mouse study in this line exists in a niche journal; it does not establish efficacy, and there are no controlled human trials. The technical section below reconstructs the claimed two-chamber topology from the published descriptions.
The donor node is, per the patents, a biodonor organism (young sprouts). Fringe texts in this line mention other donor variants.
Zakharov — patent inset. A smaller branch is Yu. A. Zakharov's RU 97636 (2009), a “living mask” that places germinating sprouts against facial or scalp skin to “transfer electromagnetic radiation” from the seedlings; the accompanying theory names a “mis-coordination of cellular wave interaction” corrected by a young-organism field. A device of this line is reported operating near Domodedovo. (The utility model lapsed in 2012.)
The claim — transfer of biological or hereditary field information from young organisms, driving rejuvenation or cure — has no clinical evidence and contradicts established developmental biology and biophysics: there is no known channel by which focused plant photon emission could rewrite a recipient's physiology. That places the doctrine in the strong-rejection tier on the contradicts-established-science axis — distinct from the tested-not-confirmed devices, where a real measurement merely awaits a valid reading. The grade is F: not “awaiting a trial” but at odds with known mechanism. Note the separate axes — the geometry is physically plausible as hardware, yet the therapeutic claim still grades F. Plausibility of the box is not evidence for the cure.
The Russian utility patents (RU 2533058, RU 97636) are intellectual-property facts: they attest that a design was filed, not that it works, and not that any regulator authorised it as a treatment. A reported installation is likewise a market fact, not evidence. No FDA, EU-MDR, NMPA, or TGA clearance exists for the chamber as a therapy.
Two unrelated things share the name and must not be confused with the rejuvenation chamber:
Construction above is from published texts and patents only — no private photographs; the schematic is a layout, not a measured drawing.
Registration or clearance is a market-access fact, never proof of efficacy.
| US — FDA | None. |
|---|---|
| EU — MDR | None. |
| Russia | Russian utility patents — RU 2533058 (Komrakov, Biotron-EKOM) and RU 97636 (Zakharov, 'Living Mask'). A patent is an intellectual-property fact, not a marketing authorization and not efficacy. |
| China — NMPA | None identified for the chamber; the Jiang-Kanzheng origin is marketed in China — see the Jiang Kanzheng entry. |
| Australia — TGA | None. |
Patents are IP facts, not efficacy: Komrakov 'Biotron-EKOM' (RU 2533058; international family WO2011028147A2) and Zakharov 'Living Mask' (RU 97636, lapsed 2012). Self-published / non-peer-reviewed primaries in this line (lifextron.com, enio.dp.ua) are named for the record, not endorsed; a niche-journal mouse study does not establish efficacy. All efficacy claims unverified.